← Evidence map

ArticleBlood2023

High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma.

Mehmet Kemal Samur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

30 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36603186